Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$17.83 - $29.12 $1.17 Million - $1.91 Million
-65,466 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$27.86 - $35.93 $1.29 Million - $1.66 Million
-46,155 Reduced 41.35%
65,466 $1.89 Million
Q4 2019

Feb 12, 2020

BUY
$13.55 - $26.15 $1.51 Million - $2.92 Million
111,621 New
111,621 $2.73 Million

Others Institutions Holding OYST

About Oyster Point Pharma, Inc.


  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Board Of Trustees Of The Leland Stanford Junior University Portfolio

Follow Board Of Trustees Of The Leland Stanford Junior University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Board Of Trustees Of The Leland Stanford Junior University, based on Form 13F filings with the SEC.

News

Stay updated on Board Of Trustees Of The Leland Stanford Junior University with notifications on news.